XML 40 R29.htm IDEA: XBRL DOCUMENT v3.21.1
FAIR VALUE MEASUREMENTS (Tables)
9 Months Ended
Mar. 31, 2021
Fair Value Disclosures [Abstract]  
Schedule of financial assets and liabilities measured at fair value on a recurring basis
The following table presents the Company’s hierarchy for its financial assets and liabilities measured at fair value on a recurring basis as of March 31, 2021:

(In millions)Level 1Level 2Level 3Total
Assets:
Money market funds$3,518 $— $— $3,518 
Foreign currency forward contracts
— 136 — 136 
Interest rate-related derivatives
— — 
Total
$3,518 $143 $— $3,661 
Liabilities:
Foreign currency forward contracts
$— $129 $— $129 
Interest rate-related derivatives
— 15 — 15 
Contingent consideration
— — 
Total
$— $144 $$146 
The following table presents the Company’s hierarchy for its financial assets and liabilities measured at fair value on a recurring basis as of June 30, 2020:

(In millions)Level 1Level 2Level 3Total
Assets:
Money market funds$2,810 $— $— $2,810 
Foreign currency forward contracts
— 87 — 87 
Interest rate-related derivatives
— 15 — 15 
Total
$2,810 $102 $— $2,912 
Liabilities:
Foreign currency forward contracts
$— $80 $— $80 
Interest rate-related derivatives
— — 
Contingent consideration
— — 
Total
$— $83 $$87 
Schedule of estimated fair values of financial instruments
The estimated fair values of the Company’s financial instruments are as follows:

March 31
2021
June 30
2020
(In millions)Carrying
Amount
Fair
Value
Carrying
Amount
Fair
Value
Nonderivatives
Cash and cash equivalents
$6,399 $6,399 $5,022 $5,022 
Current and long-term debt
5,958 6,465 6,136 6,902 
Contingent consideration
Derivatives
Foreign currency forward contracts – asset (liability), net
Interest rate-related derivatives – asset (liability), net
(8)(8)12 12 
Impairment charges measured at fair value on a nonrecurring basis, classified as Level 3
The following table presents the Company’s impairment charges for the nine months ended March 31, 2021 for certain of its nonfinancial assets measured at fair value on a nonrecurring basis, classified as Level 3, due to a change in circumstances that triggered an interim impairment test:

(In millions)Impairment chargesDate of Fair Value Measurement
Fair Value(1)
Goodwill
GLAMGLOW$54 November 30, 2020$— 
BECCA(2)
13 February 28, 2021— 
Total67 — 
Other intangible assets, net (trademark and customer lists)
GLAMGLOW27 November 30, 202036 
BECCA(2)
34 February 28, 2021— 
Total61 36 
Long-lived assets33 March 31, 202135 
Total$161 $71 
(1)See Note 3 - Goodwill and Other Intangible Assets for discussion of the valuation techniques used to measure fair value, the description of the inputs and information used to develop those inputs.
(2)See Note 4 – Charges Associated with Restructuring and Other Activities for further information relating to goodwill and other intangible asset impairment charges recorded in connection with the exit of the global distribution of BECCA products.

The following table presents the Company’s impairment charges for the nine months ended March 31, 2020 for certain of its nonfinancial assets measured at fair value on a nonrecurring basis, classified as Level 3, due to a change in circumstances that triggered an interim impairment test:

(In millions)Impairment chargesDate of Fair Value Measurement
Fair Value(1)
Goodwill$786 March 31, 2020$103 
Other intangible assets, net (trademark)324 March 31, 2020417 
Long-lived assets13 March 31, 202011 
Total$1,123 $531 
(1)See Note 3 - Goodwill and Other Intangible Assets for discussion of the valuation techniques used to measure fair value, the description of the inputs and information used to develop those inputs.
Changes in the fair value of the contingent consideration obligations
Changes in the fair value of the contingent consideration obligations for nine months ended March 31, 2021 are included in Selling, general and administrative expenses in the accompanying consolidated statements of earnings (loss) and were as follows:

(In millions)
Fair Value
Contingent consideration at June 30, 2020$
Changes in fair value
(2)
Contingent consideration at March 31, 2021$